Status:
UNKNOWN
An Assessment of the Occurrence of Hypothyroidism in Patients Treated With RAI for Hyperthyroidism.
Lead Sponsor:
Universitair Ziekenhuis Brussel
Conditions:
Nodule Solitary Thyroid
Toxic Multinodular Goiter
Eligibility:
All Genders
18+ years
Brief Summary
Low RAIU in patients with hyperthyroidism represents a common obstacle in the treatment with RAI. Therefore, a higher dose of RAI must be administered to cure hyperthyroidism in these patients. If we ...
Eligibility Criteria
Inclusion
- Hyperthyroid patients, either subclinical or overt, who have undergone RAI treatment in the period of 2005-2015.
Exclusion
- Prior use of L-thyroxine
- Prior thyroid surgery
- Prior RAI treatment
- Patients with thyroiditis
Key Trial Info
Start Date :
September 11 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2021
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04663451
Start Date
September 11 2020
End Date
May 1 2021
Last Update
April 19 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitair Ziekenhuis Brussel
Brussels, Belgium, 1090